Stellarix shares how carbon capture technologies like CCS and DAC are helping energy companies reduce emissions and meet global sustainability goals.

LOS ANGELES, April 25, 2025 /PRNewswire-PRWeb/ — As global efforts to combat climate change intensify, energy companies are facing growing pressure to reduce their carbon footprint. Traditional energy production methods are no longer enough to meet evolving environmental expectations. In response, many businesses are turning to carbon capture technologies to support their transition toward cleaner operations.

Stellarix, a global leader in sustainability and R&D strategy, is helping energy companies implement effective carbon capture initiatives that balance regulatory compliance, innovation, and long-term environmental goals. With expertise in carbon capture, utilization, and storage (CCUS), Stellarix develops tailored solutions that enable companies to reduce emissions while maintaining growth.

The Growing Importance of Carbon Capture in Energy

Carbon capture and sequestration (CCS) is gaining widespread adoption as a practical solution to reduce greenhouse gas emissions. According to the International Energy Agency (IEA), CCS could account for up to 15% of the emissions reductions required to reach net-zero targets by 2050. These technologies capture CO₂ directly from industrial sources like power plants and factories, preventing it from being released into the atmosphere.

With clients in over 70 countries and more than 15 years of experience, Stellarix supports energy companies at every step of their carbon capture journey. From planning and R&D to commercialization, the company’s deep industry knowledge helps organizations deploy sustainable strategies that are both efficient and future-ready.

How Stellarix Supports the Energy Sector

Stellarix offers a range of services designed to help energy companies integrate carbon capture technologies effectively. These include:

Strategic Foresight: Identifying emerging risks and opportunities to ensure carbon capture efforts are aligned with business and sustainability goals.R&D Strategy: Guiding businesses from early-stage research to product development and market launch of carbon capture technologies.Sustainability Services: Developing tailored roadmaps to help businesses reduce their environmental impact and meet ESG standards.CCS Implementation: Advising on the design and deployment of carbon capture and storage solutions to efficiently manage industrial emissions.Partner Scouting: Connecting clients with strategic partners and stakeholders to drive innovation and accelerate project success.Startup Support: Assisting new and emerging energy ventures in launching scalable carbon capture technologies. 

Emerging Trends in Carbon Capture

Several technologies are driving innovation in the carbon capture space, including:

Carbon Capture and Storage (CCS): A mature technology that captures up to 90% of CO₂ emissions from industrial processes and stores it underground.Direct Air Capture (DAC): Captures CO₂ directly from the atmosphere, offering new opportunities for offsetting emissions.Bioenergy Carbon Capture: Combines renewable energy generation with carbon removal, creating a dual benefit of clean energy and emissions reduction.CCUS (Carbon Capture, Utilization, and Storage): Transforms captured CO₂ into valuable products such as fuels and industrial chemicals, reducing waste while adding economic value.

These innovations are critical to helping the energy sector meet growing regulatory demands and contribute to climate mitigation efforts.

A Trusted Partner for the Net-Zero Transition

As the energy landscape shifts, companies need experienced partners to navigate the complexities of sustainability and compliance. Stellarix provides end-to-end guidance and technical support to help clients adopt carbon capture in a way that aligns with their operational and environmental goals.

The Global CCS Institute projects that global CO₂ capture capacity is expected to double to more than 100 million tonnes per year as new facilities come online. This signals growing momentum in the adoption of carbon capture technologies across industries.

Stellarix is committed to staying ahead of regulatory changes and equipping businesses with the tools they need to stay competitive, compliant, and environmentally responsible.

About Stellarix

Stellarix is a global innovation and sustainability consulting firm that specializes in helping energy companies implement advanced carbon capture strategies. With over 15 years of experience and a footprint in 70+ countries, Stellarix delivers R&D planning, sustainability services, and CCUS solutions that support a more sustainable future.

Media Contact

Sonam Rara, Stellarix Consultancy Services Pvt. Ltd., 0141 492 0704, media@stellarix.com, https://stellarix.com/

View original content to download multimedia:https://www.prweb.com/releases/stellarix-highlights-how-carbon-capture-solutions-support-the-evolving-energy-sector-302438301.html

SOURCE Stellarix

“Why is it so difficult to move photos and movies from iphone to computer without itunes?” How to transfer pictures from iphone to computer easily? Tenorshare iCareFone 1 Click Transfer!

HONG KONG, April 25, 2025 /PRNewswire/ — iTunes does not support certain file types or devices, and it may transfer slowly, causing problems such as “Your account has been disabled in iTunes” and data loss. So move photos and movies from iphone to computer via itunes can be tricky and risky. Unlike transfer pics from Android to PC, iPhone file transfers are not smooth enough, forcing users to reconsider upgrading.

Why Tenorshare iCareFone (All-in-One Free iOS Backup and File Manager)?

Tenorshare iCareFone is the best way to copy photos and videos from iphone to your computer without iTunes in 2025, offers a user-friendly and easily 1 click transfer operating system, and supports up to transfer high quality contacts, music, videos, messages from iPhone/iPad to Windows or Mac directly, suitable for ordinary users and professional technicians.

Key Features of Tenorshare iCareFone:

No need for iTunes, Multiple Sync: Transfer photos, videos, APP and other data between computer, iPhone and Android with original details.Selective Pick & Transfer: Select specific photos or albums selectively. One-click transfer, simpler operation, non-tech background required.Suitable for large-volume photos and videos Transfer: Safe Transfer Keep all your existing data original quality, keep perfect details.Free download and features: iOS data backup, developer mode, iPhone test, AI wallpaper.Supported Windows 11/10/8.1/8/7, macOS 15/14/13/12, and compatible with all iOS 18/17/16, all iPhone version and iPad, and iPod Touch.

How to Import Photos from iPhone to PC (Windows11/10) Without iTunes?

Step1. Install Tenorshare iCareFone Transfer software on your Windows or Mac

Step2. Select all or individual files or photos you want to export to Mac or Windows, and then click the ‘One-click Export’ button.

Step3. Then Successfully to export photos to your laptop device from iPhone Now!

Other 4 Ways to Transfer photos and videos from your iPhone or iPad to your Mac or PC

Way2. Via USB transfer: Connect iPhone and computer via USB>Click “Start”>Select ‘Import’ then transfer your Photos.

Way3. Transfer Photos via iCloud Photos: Select photos from iPhone to back up to iCloud and upload them on your computer

Way4. Use AirDrop: Open Airdrop to send photos and videos to your Mac quickly.

Way5. Use Hard Disk or SD: Go to the Photos app on your Mac, Copy the Photos and videos to Computer.

In short, these methods require a certain technical background, the quick and simple way is Tenorshare iCareFone. Even if you’re not tech-savvy. Just download iCareFone, follow the steps, and move your photos in seconds.

Press Contact:

Angel Harrison
15889757098
https://www.tenorshare.com/ 

View original content to download multimedia:https://www.prnewswire.com/news-releases/5-ways-to-transfer-photos-from-phone-to-pc-2025-tenorshare-icarefone-302438345.html

SOURCE Tenorshare

PredxBio today announced the official launch of enhanced SpaceIQ™ platform to integrate brightfield, spatial proteomics and transcriptomics datasets to deliver a unified, high-resolution view of the tumor microenvironment—unlocking new insights into cellular interactions, immune architecture, and mechanisms of therapeutic response and resistance. This milestone launch, timed ahead of the American Association for Cancer Research (AACR) Annual Meeting 2025, will be highlighted by two scientific poster presentations and a spotlight symposium at the conference. The new capabilities of SpaceIQ™ are poised to accelerate insights in cancer biology, improve patient stratification, and drive advances in precision immuno-oncology.

PITTSBURGH, April 25, 2025 /PRNewswire-PRWeb/ — PredxBio today announced the official launch of enhanced SpaceIQ™ platform to integrate brightfield, spatial proteomics and transcriptomics datasets to deliver a unified, high-resolution view of the tumor microenvironment—unlocking new insights into cellular interactions, immune architecture, and mechanisms of therapeutic response and resistance. This milestone launch, timed ahead of the American Association for Cancer Research (AACR) Annual Meeting 2025, will be highlighted by two scientific poster presentations and a spotlight symposium at the conference. The new capabilities of SpaceIQ™ are poised to accelerate insights in cancer biology, improve patient stratification, and drive advances in precision immuno-oncology.

SpaceIQ™ is an explainable AI-driven spatial multiomics platform that provides a rigorous framework to interrogate the tumor microenvironment. With its latest upgrade, SpaceIQ™ can now ingest and co-analyze brightfield, spatial proteomics and transcriptomics datasets from tumor samples. Researchers are able to map gene expression profiles onto tissue architecture and identify complex cellular neighborhoods (or “microdomains”) that drive tumor progression and immune evasion. By leveraging probabilistic modeling and unbiased cell typing, SpaceIQ™ uncovers transition cell states, cell–cell interactions, and mechanistic pathway networks within the tumor – yielding a deeper understanding of tumor heterogeneity and therapy resistance.

“PredxBio’s unique capabilities in unbiased cell typing and explainable AI allow us to decode the mechanistic complexities of the tumor microenvironment,” said S. Chakra Chennubhotla, PhD, Chief of AI at PredxBio. “By integrating multiomic spatial data with SpaceIQ™, we are advancing the frontier of precision oncology – translating these insights into actionable solutions for patient care.”

At AACR 2025 in Chicago, PredxBio and its collaborators will present two new studies showcasing SpaceIQ™’s impact:

Poster 1 (Abstract #2485): “A Bayesian Framework for Unraveling Disease Biology from Spatially Resolved Single-Cell Omics Datasets.” Co-authored in collaboration with Arutha Kulasinghe, PhD, Director of the Queensland Spatial Biology Centre, this poster introduces a novel Bayesian approach for analyzing high-dimensional spatial single-cell data. Presentation Time: April 28, 2025, 9:00 AM–12:00 PM CT (Poster Section 47, Board #6). The study demonstrates how combining unbiased computational methods with biological priors in SpaceIQ™ can reveal emergent cell types and microdomains, offering new insights into disease mechanisms.Poster 2 (Abstract #5317): “Multimodal Spatial Analysis of Colon Cancer Tissue Reveals Emergence of an Immunosuppressive Tumor Maintenance Mechanism.” Co-authored by Gaurav N. Joshi, PhD, and colleagues from Nikon BioImaging Lab in Boston, this research applies SpaceIQ™ to a colon cancer sample by integrating mIF and spatial transcriptomics. Presentation Time: April 29, 2025, 2:00 PM–5:00 PM CT (Poster Section 8, Board #23). This study uncovers how tumor and immune cells are spatially organized to create an immunosuppressive microenvironment that supports tumor maintenance.

“Using SpaceIQ’s multiomic analysis, we discovered an immunosuppressive mechanism in colon cancer that would have been difficult to detect with single-modality data,” noted Gaurav N. Joshi, PhD, lead author of the colon cancer study. “By combining brightfield, spatial proteomics and transcriptomics datasets, we can see how different immune cells and signals interact within the tumor microenvironment. This level of insight is invaluable for precision immuno-oncology, as it points to biomarkers and therapeutic targets that can inform more effective, personalized treatments.”

Spotlight Symposium at AACR 2025

The launch of SpaceIQ™ will also be highlighted during a Spotlight Theater Symposium titled:

“Harnessing Spatial Multiomic Biomarkers: Ushering in a New Era of Precision Oncology”

Date: Sunday, April 27, 2025Time: 3:30 PM – 4:30 PM CTLocation: Spotlight Theater D, McCormick Place, Chicago

The session will begin with a joint presentation by B. Dusty Majumdar, PhD, S. Chakra Chennubhotla, PhD, and A/Prof. Arutha Kulasinghe, followed by a panel discussion featuring spatial biology experts from academia and industry. Attendees will hear how SpaceIQ™ can be applied to decode tumor complexity and guide biomarker discovery, patient stratification, and companion diagnostic development.

Visit PredxBio at AACR 2025

Exhibit Booth: #3252Conference Dates: April 26–30, 2025Venue: McCormick Place, Chicago, IL

Attendees are invited to stop by the booth for hands-on demonstrations and to learn how SpaceIQ™ is enabling faster, more informed decisions in drug development, biomarker discovery, and patient stratification.

About PredxBio

PredxBio is a spatial analytics company headquartered in Pittsburgh, PA, powering next-generation cancer therapeutics with its AI-driven spatial biomarkers. PredxBio’s proprietary approaches delve into the mechanism of action of drugs and predict patient outcomes with over 90% accuracy. By transforming multiplexed biopsy images and multi-modal spatial data into actionable insights – and revealing the network biology of cancer – PredxBio is setting new standards for biomarker discovery and clinical research. In partnership with leading pharmaceutical companies and research institutions, PredxBio is accelerating drug discovery and advancing personalized medicine to impact cancer patients globally. For more information, visit www.predxbio.com

Media Contact

A. Burak Tosun, PredxBio, 1 4122123115, info@predxbio.com, www.predxbio.com

LinkedIn

View original content:https://www.prweb.com/releases/predxbio-launches-enhanced-spaceiq-platform-with-multiomic-spatial-capabilities-ahead-of-aacr-2025-302438004.html

SOURCE PredxBio